-
公开(公告)号:US20230203058A1
公开(公告)日:2023-06-29
申请号:US17917462
申请日:2021-04-07
申请人: ITEOS BELGIUM SA
IPC分类号: C07D498/08 , A61P35/00 , C07D487/08 , C07D487/18 , C07D273/08 , A61K45/06 , A61K31/551 , A61K31/395
CPC分类号: C07D498/08 , A61K31/395 , A61K31/551 , A61K45/06 , A61P35/00 , C07D273/08 , C07D487/08 , C07D487/18
摘要: The present invention relates to macrocyclic diamine derivatives of formula II, including pharmaceutically acceptable salts and solvates thereof. Compounds of the invention are inhibitors of ENT family transporter, especially of ENT1, and are useful as therapeutic compounds for the treatment of cancers. The invention also relates to the combined use of the macrocyclic diamine derivatives with an adenosine receptor antagonist, for the treatment of cancers.
-
公开(公告)号:US20230146675A1
公开(公告)日:2023-05-11
申请号:US17895667
申请日:2022-08-25
申请人: ITEOS BELGIUM SA
IPC分类号: C07D487/04 , C07D513/14
CPC分类号: C07D487/04 , C07D513/14
摘要: The present invention relates to pyrimido[5,4-d]pyrimidine derivatives of formula I, including pharmaceutically acceptable salts and solvates thereof.
Compounds of the invention are inhibitors of ENT family transporter, especially of ENT1, and are useful as therapeutic compounds for the treatment of cancers. The invention also relates to the combined use of the pyrimido[5,4-d]pyrimidine derivatives with an adenosine receptor antagonist, for the treatment of cancers.
-